AI assistant
CONMED Corp — Director's Dealing 2022
Mar 1, 2022
31971_dirs_2022-03-01_ed79d3f9-2848-423f-b082-8722efb74d42.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-02-25
Reporting Person: Jonas Daniel S (EVP Legal Affairs,Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-25 | Common Stock | M | 500 | $78.76 | Acquired | 12667 | Direct |
| 2022-02-25 | Common Stock | S | 500 | $150.0307 | Disposed | 12167 | Direct |
| 2022-02-25 | Common Stock | M | 3343 | $78.76 | Acquired | 15510 | Direct |
| 2022-02-25 | Common Stock | S | 3343 | $149.4112 | Disposed | 12167 | Direct |
| 2022-02-25 | Common Stock | M | 1245 | $97.69 | Acquired | 13412 | Direct |
| 2022-02-25 | Common Stock | S | 1245 | $150.00 | Disposed | 12167 | Direct |
| 2022-02-25 | Common Stock | M | 3755 | $97.69 | Acquired | 15922 | Direct |
| 2022-02-25 | Common Stock | S | 3755 | $149.4557 | Disposed | 12167 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-25 | Options To Purchase Common Stock | $78.76 | M | 500 | Disposed | 2029-03-01 | Common Stock (500) | Direct |
| 2022-02-25 | Options To Purchase Common Stock | $78.76 | M | 3343 | Disposed | 2029-03-01 | Common Stock (3343) | Direct |
| 2022-02-25 | Options To Purchase Common Stock | $97.69 | M | 1245 | Disposed | 2030-03-02 | Common Stock (1245) | Direct |
| 2022-02-25 | Options To Purchase Common Stock | $97.69 | M | 3755 | Disposed | 2030-03-02 | Common Stock (3755) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.16. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.56. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period